Sutro Biopharma, Inc. (NASDAQ:STRO) Given Average Rating of

Shares of Sutro Biopharma, Inc. (NASDAQ:STRO – Get Rating) have received a consensus rating of “Moderate Buy” from the six ratings firms that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating on the company. The average 1 year […]

Related Keywords

New York , United States , Jamesr Swartz , Sutro Biopharma , Wells Fargo Company , York State Common Retirement Fund , Sutro Biopharma Company Profile , Sutro Biopharma Inc , Jump Financial , Nasdaq , Allspring Global Investments Holdings , Get Rating , Biopharma Inc , Sutanto Widjaja , South San Francisco , Sutro Biopharma Daily , Nasdaq Stro , Castro , Medical , Ratings , Consensus ,